Results 151 to 160 of about 2,705 (182)

Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh. [PDF]

Vaccine
Weyant C, Hooda Y, Munira SJ, Lo NC, Ryckman T, Tanmoy AM, Kanon N, Seidman JC, Garrett D, Saha SK, Goldhaber-Fiebert JD, Saha S, Andrews JR.   +12 more
europepmc   +1 more source

Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey - Harare, Zimbabwe, 2019. [PDF]

Vaccine
Gharpure R, Longley AT, Takamiya M, Hidle A, Munyanyi M, Chawurura T, Maxwell L, Mamire G, Chaora G, Chakauya J, Rupfutse M, Poncin M, Gasasira A, Date K, Manangazira P, Sreenivasan N.   +15 more
europepmc   +1 more source

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age. [PDF]

Vaccine
Bijukchhe SM, Gurung M, Pokhrel B, Shakya M, Pant D, Maskey P, Maskey H, Dhakal B, Rajkarkinar S, Bista S, Voysey M, Mujadidi YF, Kim YC, Atherton R, Jones E, Mclean F, Shrestha S, Hill M, Nyland KT, Kelly S, O'reilly P, Sah GP, Basnyat B, Pollard AJ, Shrestha S.   +24 more
europepmc   +1 more source

The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.

Lancet Glob Health
Feng S, Zhang Y, Khanam F, Voysey M, Pitzer VE, Qadri F, Clemens JD, Pollard AJ, Liu X.   +8 more
europepmc   +1 more source

Population structure and evolution of Salmonella enterica serotype Typhi in Zimbabwe before a typhoid conjugate vaccine immunization campaign

, 2022
Thilliez G, Mashe T, Chaibva BV, Robertson V, Bawn M, Tarupiwa A, Takawira FT, Kock MM, Midzi S, Mwamakamba LW, Matheu J, Kingsley RA, Ehlers MM.   +12 more
europepmc   +1 more source

Conjugate typhoid vaccine(s) in the Indian context.

Indian pediatrics, 2009
openaire   +1 more source

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)

Cochrane Database of Systematic Reviews, 2023
The original publication is available: https://www.cochranelibrary.com/Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:.
Natasha R Gloeck, Trudy Leong, Chinwe Juliana Iwu-Jaja, Patrick de Marie Katoto, Tamara Kredo, Charles S Wiysonge   +5 more
openaire   +3 more sources

Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?

Clinical Infectious Diseases, 2019
The health consequences of typhoid, including increasing prevalence of drug-resistant strains, can stress healthcare systems. While vaccination is one of the most successful and cost-effective health interventions, vaccine introduction can take years and
Leslie P Jamka, Adwoa D Bentsi-Enchill, Andrew J Pollard   +2 more
exaly   +3 more sources

Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal

New England Journal of Medicine, 2019
BACKGROUND Salmonella Typhi is a major cause of fever in children in low- and middle-income countries. A typhoid conjugate vaccine (TCV) that was recently prequalified by the World Health Organization was shown to be efficacious in a human challenge ...
Rachel Colin-Jones, Katherine Theiss-Nyland, Merryn Voysey   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Polysaccharide Conjugate Typhoid Vaccine

New England Journal of Medicine, 2001
There is a growing appreciation of the huge health threat posed by increasingly resistant infectious diseases, especially in tropical areas of the developing world.
R L, Guerrant, M, Kosek
openaire   +2 more sources